Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Aptamer Group (APTA) Share Price

Price 0.975p on 23-12-2025 at 19:40:04
Change 0.09p 11.25%
Buy 1.05p
Sell 0.90p
Last Trade: Sell 676,653.00 at 0.89p
Day's Volume: 14,542,338
Last Close: 0.89p
Open: 0.90p
ISIN: GB00BNRRP542
Day's Range 0.89p - 0.89p
52wk Range: 0.23p - 1.30p
Market Capitalisation: £24.00m
VWAP: 0.913338p
Shares in Issue: 2.70b

Aptamer Group (APTA) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 676,653 0.89p Uncrossing Trade
16:40:43 - 23-Dec-25
Sell* 599,999 0.9356p Ordinary
16:28:17 - 23-Dec-25
Sell* 344,925 0.9333p Ordinary
16:25:44 - 23-Dec-25
Unknown* 1,021,554 0.9789p Ordinary
16:20:50 - 23-Dec-25
Sell* 364,426 0.92666p Ordinary
16:17:06 - 23-Dec-25
Sell* 125,000 0.92666p Ordinary
16:05:23 - 23-Dec-25
Buy* 500,000 0.98333p Ordinary
16:02:11 - 23-Dec-25
Sell* 50,000 0.9255p Ordinary
15:59:16 - 23-Dec-25
Sell* 300,000 0.92p Ordinary
15:50:06 - 23-Dec-25
Buy* 526,315 0.95p Ordinary
15:31:51 - 23-Dec-25
See more Aptamer Group trades

Aptamer Group (APTA) Share Price History

Time period:
to
Date Open High Low Close Volume
23rd Dec 2025 (Tue) 0.90 0.89 0.89 0.89 14,542,338
22nd Dec 2025 (Mon) 0.75 0.80 0.75 0.80 4,462,782
19th Dec 2025 (Fri) 0.80 0.80 0.75 0.75 11,557,814
18th Dec 2025 (Thu) 0.80 0.80 0.80 0.80 8,496,784
17th Dec 2025 (Wed) 0.85 0.85 0.80 0.80 11,468,939
16th Dec 2025 (Tue) 0.775 0.85 0.775 0.85 16,897,230
15th Dec 2025 (Mon) 0.775 0.775 0.74 0.775 3,256,741
12th Dec 2025 (Fri) 0.80 0.80 0.775 0.775 5,606,297
11th Dec 2025 (Thu) 0.775 0.80 0.775 0.80 2,814,677
10th Dec 2025 (Wed) 0.80 0.75 0.75 0.75 7,863,740
9th Dec 2025 (Tue) 0.80 0.80 0.80 0.80 246,605
8th Dec 2025 (Mon) 0.80 0.80 0.80 0.80 2,922,269
5th Dec 2025 (Fri) 0.80 0.80 0.80 0.80 759,385
4th Dec 2025 (Thu) 0.85 0.85 0.80 0.80 6,629,712
3rd Dec 2025 (Wed) 0.85 0.85 0.84 0.85 2,335,146
2nd Dec 2025 (Tue) 0.825 0.85 0.825 0.85 2,719,424
1st Dec 2025 (Mon) 0.85 0.85 0.825 0.825 811,798
28th Nov 2025 (Fri) 0.85 0.85 0.85 0.85 1,655,649
27th Nov 2025 (Thu) 0.85 0.85 0.85 0.85 6,725,400
26th Nov 2025 (Wed) 0.825 0.85 0.825 0.85 2,297,071
25th Nov 2025 (Tue) 0.825 0.825 0.825 0.825 2,560,740
24th Nov 2025 (Mon) 0.90 0.93 0.93 0.93 7,787,358
See more Aptamer Group price history

Aptamer Group (APTA) Share News

IN BRIEF: Aptamer signs Optimer contract with US biotech Alphazyme

23rd Dec 2025 13:26

Aptamer Group PLC - York, England-based synthetic binders developer - Strikes licensing agreement with Alphazyme Inc. This grants Jupiter, Florida-based biotechnology company Alphazyme a non-exclusive licence for use of an enzyme-modulating Optimer in hot-start polymerase chain reaction and next-generation sequencing applications within Alphazyme's own products and services. Optimer binders are advanced molecules that work like antibodies by attaching to specific targets in the body. Read More

EARNINGS AND TRADING: Saga insurance partnership with Ageas goes live

16th Dec 2025 21:39

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

Aptamer hails two "key" contract wins; eyes revenue to beat prior year

14th Nov 2025 11:58

(Alliance News) - Aptamer Group PLC on Friday announced new contracts as it expects annual revenue to further grow. Read More

IN BRIEF: Aptamer hails new contract with "top 5 pharma company"

4th Nov 2025 14:33

Aptamer Group PLC - York, England-based synthetic binders developer - Wins new contract with a "top five pharmaceutical company" with a value of up to GBP617,000. It says the contract is the third with this pharmaceutical company and represents "strong validation" of the Optimer platform. Under the agreement, Aptamer will develop Optimer binders against three key drug targets. Further, Aptamer will provide critical support for ELISA assay development. "These tools will enable the partner to validate drug candidates and may also be used to analyse patient samples during clinical trials, potentially leading to clinical diagnostic development," Aptamer says. Read More

AIM WINNERS & LOSERS: Aptamer wins contract; Image Scan swings to loss

4th Nov 2025 11:22

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday. Read More

See more Aptamer Group news
FTSE 100 Latest
Value9,889.22
Change23.25

Login to your account

Forgot Password?

Not Registered